# Merit Medical Systems, Inc. clinical trials: 29 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials with Merit Medical Systems, Inc. as lead sponsor, 4 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Merit Medical Systems, Inc.: 29 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/merit-medical-systems-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 4
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 4, 2025 | NCT06807099 | WRAP North America | Merit Medical Systems, Inc. | Observational | Recruiting | Venous Stenosis, Venous Occlusion | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06807099) |
| September 19, 2024 | NCT06587282 | PREEMIE: Study for Treatment of PDA in Premature Infants | Merit Medical Systems, Inc. | Not applicable | Active not recruiting | Patent Ductus Arteriosus (PDA) | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06587282) |
| May 21, 2024 | NCT06422871 | PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis | Merit Medical Systems, Inc. | Observational | Recruiting | End Stage Renal Disease, Hemodialysis Access Failure | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06422871) |
| December 1, 2023 | NCT06153667 | Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) | Merit Medical Systems, Inc. | Observational | Recruiting | Uterine Fibroid | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06153667) |
| April 18, 2023 | NCT05818150 | GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION) | Merit Medical Systems, Inc. | Not applicable | Active not recruiting | Knee Osteoarthritis | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05818150) |
| April 1, 2022 | NCT05307783 | EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging | Merit Medical Systems, Inc. | Observational | Completed | Hemorrhage, Bleeding Hemorrhage | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05307783) |
| September 30, 2021 | NCT05062291 | Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP) | Merit Medical Systems, Inc. | Observational | Active not recruiting | Venous Stenosis, Venous Occlusion | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05062291) |
| September 21, 2021 | NCT05050799 | US Post-Market Surveillance Study of the Surfacer System | Merit Medical Systems, Inc. | Observational | Recruiting | Venous Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05050799) |
| April 29, 2021 | NCT04866290 | HepaSphere™ Microspheres Prospective Registry | Merit Medical Systems, Inc. | Observational | Completed | Metastatic Colorectal Cancer | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04866290) |
| March 25, 2021 | NCT04815291 | Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc ) | Merit Medical Systems, Inc. | Not applicable | Terminated | Breast Cancer | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04815291) |
| September 9, 2020 | NCT04541576 | The Merit WRAPSODY Central Feasibility Study | Merit Medical Systems, Inc. | Not applicable | Withdrawn | Venous Stenosis, Venous Occlusion | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04541576) |
| September 7, 2020 | NCT04540302 | The Merit WRAPSODY AV Access Efficacy Study (WAVE) | Merit Medical Systems, Inc. | Not applicable | Completed | Venous Stenosis, Venous Occlusion | 357 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04540302) |
| June 21, 2019 | NCT03994185 | The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease | Merit Medical Systems, Inc. | Not applicable | Withdrawn | Stenosis of Artery, Peripheral Arterial Disease, Iliac Artery Disease, Iliac Artery Occlusion | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03994185) |
| August 23, 2018 | NCT03644017 | The Merit WRAPSODY™ Endovascular Stent Graft | Merit Medical Systems, Inc. | Not applicable | Completed | Venous Stenosis, Venous Occlusion | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03644017) |
| May 17, 2018 | NCT03527589 | Embosphere® PROstate Post Market Study | Merit Medical Systems, Inc. | Observational | Completed | Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | 499 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03527589) |
| October 17, 2017 | NCT03311451 | C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study. | Merit Medical Systems, Inc. | Not applicable | Active not recruiting | Barrett Esophagus | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03311451) |
| July 6, 2017 | NCT03209050 | Evaluation of the Surfacer System Approach to Central Venous Access | Merit Medical Systems, Inc. | Not applicable | Completed | Venous Occlusion | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03209050) |
| August 23, 2016 | NCT02875899 | Surfacer System to Facilitate Access in Venous Occlusions | Merit Medical Systems, Inc. | Observational | Completed | Chronic Venous Thrombosis, Venous Thrombosis Upper Extremity, Venous Thrombosis Upper Extremity Superficial Veins | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02875899) |
| April 17, 2015 | NCT02419703 | The STAR™ Tumor Ablation Registry | Merit Medical Systems, Inc. | Observational | Terminated | Metastatic Lesions in Vertebral Bodies | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02419703) |
| January 28, 2015 | NCT02349308 | Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter | Merit Medical Systems, Inc. | Observational | Completed | Pain; Dialysis Catheter | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02349308) |
| August 26, 2014 | NCT02225223 | Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s) | Merit Medical Systems, Inc. | Not applicable | Terminated | Metastatic Lesions in Vertebral Bodies | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02225223) |
| June 16, 2014 | NCT02164175 | Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis | Merit Medical Systems, Inc. | Observational | Withdrawn | End Stage Renal Failure on Dialysis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02164175) |
| June 10, 2014 | NCT02159898 | EndoMAXX Endoluminal Valve Technology (EVT) Compared to EndoMAXX | Merit Medical Systems, Inc. | Not applicable | Completed | Malignant Esophageal Strictures | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02159898) |
| February 12, 2013 | NCT01789840 | Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia | Merit Medical Systems, Inc. | Not applicable | Terminated | Benign Prostatic Hyperplasia | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01789840) |
| July 6, 2011 | NCT01387932 | HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer | Merit Medical Systems, Inc. | Phase 3 | Terminated | Hepatocellular Carcinoma | 235 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01387932) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 3 | 1 |
| Not applicable | 14 |
| Observational | 14 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 13 |
| Terminated | 5 |
| Active not recruiting | 4 |
| Recruiting | 4 |
| Withdrawn | 3 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Kidney Failure, Chronic | 3 |
| Arteriovenous Fistula | 3 |
| Pain | 2 |
| Prostatic Hyperplasia | 2 |
| Bacteremia | 2 |
| Carcinoma, Hepatocellular | 1 |
| Spinal Cord Neoplasms | 1 |
| Urinary Retention | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Barrett Esophagus | 1 |
| Osteoarthritis, Knee | 1 |
| Renal Insufficiency | 1 |
| Leiomyoma | 1 |
| Lower Urinary Tract Symptoms | 1 |
| Ductus Arteriosus, Patent | 1 |
| Peripheral Arterial Disease | 1 |
| Peripheral Arterial Occlusive Disease 1 | 1 |
| Hemorrhage | 1 |
| Esophageal Neoplasms | 1 |
| Deglutition Disorders | 1 |
| Gastroesophageal Reflux | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Asian fusion restaurants in the United States](https://specstream.ai/data/businesses/asian-fusion-restaurants/united-states)
- [B2B oil and gas equipment companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-equipment-companies/united-states)
- [Bearing suppliers in the United States](https://specstream.ai/data/businesses/bearing-suppliers/united-states)
- [Business consulting firms in the United States](https://specstream.ai/data/businesses/business-consulting-firms/united-states)
- [Child psychiatry practices in the United States](https://specstream.ai/data/businesses/child-psychiatry-practices/united-states)
- [Contract law firms in the United States](https://specstream.ai/data/businesses/contract-law-firms/united-states)
